Kyongbo Pharmaceutical Co., Ltd (KOSE: A214390)
Health Care · Pharmaceuticals · KR
₩5,070.00
-3.43% today · +2.7% 1Y
Kyongbo Pharmaceutical Co., Ltd (KOSE: A214390) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $87.46M.
Over the last twelve months the share price has gained 2.7%, trading between 4.70K and 9.30K.
Tweenvest scores Kyongbo Pharmaceutical Co., Ltd across four factors: quality 57/100, value 53/100, growth 29/100. Its strongest factor is quality.
A214390 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $87.46M
- Revenue (TTM)
- $180.52M
- P/E
- 24.03
- EPS
- 210.97
- Dividend yield
- —
- Beta (5Y)
- 0.33
- 52-week high
- ₩9,300.00
- 52-week low
- ₩4,700.00
- Avg volume (3M)
- —
- Shares outstanding
- 23.91M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,256.11 | +0.06% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.93 | +0.63% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.78 | +0.15% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.